SCHEMBL8286392

SCHEMBL8286392

CC(=O)c1cc(C(F)(F)F)c2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c2n1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.62
CNR1 P21554 2/20 0.40
CNR2 P34972 2/20 0.40
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
NPY5R Q15761 1/20 0.38
WEE1 P30291 1/20 0.37
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
HTT P42858 1/20 0.36
TP53 P04637 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
RIPK1 Q13546 1/20 0.35
CYP1A2 P05177 1/20 0.34
PIK3CD O00329 1/20 0.34
PIK3R2 O00459 1/20 0.34
PIK3CG P48736 1/20 0.34
GSK3B P49841 2/20 0.34
ALDH1A1 P00352 1/20 0.34
AKR1C3 P42330 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285196 0.92 PDE11A (0.64) PDE11ACNR1CNR2MEN1KMT2A
SCHEMBL8285187 0.90 PDE11A (0.62) PDE11ACNR1CNR2MEN1KMT2A
SCHEMBL8286113 0.86 PDE11A (0.60) PDE11ACNR1CNR2MEN1KMT2A
SCHEMBL5871541 0.85 PDE11A (0.46) PDE11ALMNAMAPTHTTTP53
SCHEMBL8287119 0.85 PDE11A (0.56) PDE11ACNR1CNR2MEN1KMT2A
SCHEMBL8287099 0.84 PDE11A (0.56) PDE11AMEN1KMT2AMAPTTP53
SCHEMBL8285257 0.84 PDE11A (0.57) PDE11ACNR1CNR2MEN1KMT2A
SCHEMBL5872038 0.83 PDE11A (0.66) PDE11ACNR1CNR2MEN1KMT2A
SCHEMBL6879695 0.83 PDE11A (0.66) PDE11ACNR1CNR2MEN1KMT2A
SCHEMBL6879687 0.83 PDE11A (0.66) PDE11ACNR1CNR2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed